Showing results (331-340 of 550) with videos related to
Sort By:
Pageof 55
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2017
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosisAmr Alaarg, Max L Senders, Aida Varela-Moreira, et al.European Heart Journal|March 9, 2010
Mortality in adult congenital heart diseaseCarianne L Verheugt, Cuno S P M Uiterwaal, Enno T van der Velde, et al.American Heart Journal|November 25, 2010
Ventricular response to stress predicts outcome in adult patients with a systemic right ventricleMichiel M Winter, Roderick W C Scherptong, Sabina Kumar, et al.International Journal of Cardiology|April 16, 2013
Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndromeRomy Franken, Alexander W den Hartog, Vivian de Waard, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 16, 2010
RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probeWei Chen, Peter A Jarzyna, Geralda A F van Tilborg, et al.ACS Nano|May 12, 2011
Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancerAnita Gianella, Peter A Jarzyna, Venkatesh Mani, et al.Bioconjugate Chemistry|August 21, 2013
Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapyAneta J Mieszawska, YongTae Kim, Anita Gianella, et al.The American Journal of Cardiology|July 11, 2006
Pregnancy after biventricular repair for pulmonary atresia with ventricular septal defectWillem Drenthen, Petronella G Pieper, Nicole Zoon, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2013
Clinical features differ substantially between Caucasian and Asian populations of Marfan syndromeRomy Franken, Alexander W den Hartog, Liz van de Riet, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolismM G J Duffels, M N van der Plas, S Surie, et al.Pageof 55